Big Pharma Split Corp Class A (PRM) — Financial Flexibility Index
Big Pharma Split Corp Class A (PRM) has a Financial Flexibility Index of -0.01x as of June 2025. Free cash flow of CA$-144.03K (operating CF CA$-144.04K minus capex CA$3.00) represents 0% of total liabilities (CA$12.62 Million). Check Big Pharma Split Corp Class A strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Big Pharma Split Corp Class A Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Big Pharma Split Corp Class A across 8 annual periods. See Big Pharma Split Corp Class A (PRM) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Big Pharma Split Corp Class A (2017–2024)
Year-by-year free cash flow to debt coverage for Big Pharma Split Corp Class A. For the full company profile including market capitalisation, see Big Pharma Split Corp Class A market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.10x | CA$-1.30 Million | CA$-1.30 Million | CA$12.62 Million | ▼ -109.2% |
| 2023 | 1.11x | CA$11.86 Million | CA$11.86 Million | CA$10.68 Million | ▲ +1804.8% |
| 2022 | 0.06x | CA$1.13 Million | CA$1.13 Million | CA$19.37 Million | ▲ +110.0% |
| 2021 | -0.58x | CA$-9.00 Million | CA$-9.00 Million | CA$15.41 Million | ▼ -230.9% |
| 2020 | 0.45x | CA$4.35 Million | CA$4.35 Million | CA$9.75 Million | ▼ -44.1% |
| 2019 | 0.80x | CA$8.68 Million | CA$8.68 Million | CA$10.87 Million | ▲ +829.5% |
| 2018 | 0.09x | CA$1.27 Million | CA$1.27 Million | CA$14.79 Million | ▲ +103.8% |
| 2017 | -2.24x | CA$-30.95 Million | CA$-30.95 Million | CA$13.81 Million | — |